VivoSim Labs, Inc. Cost of Revenue
VivoSim Labs, Inc. (VIVS) reported Cost of Revenue of $0 for the 12-month period ending 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-14
- VivoSim Labs, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $0.00.
- VivoSim Labs, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. cost of goods and services sold for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. cost of goods and services sold for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- VivoSim Labs, Inc. cost of goods and services sold for fiscal 2025 was $5.00K.
- VivoSim Labs, Inc. cost of goods and services sold for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- VivoSim Labs, Inc. cost of goods and services sold for fiscal 2020 was $328.00K, a 31.95% decline from fiscal 2019.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $0.00 derived: sum of 2 quarters · filed 2026-07-14 | $0.00 derived: sum of 3 quarters · filed 2026-07-14 | $0.00 10-K · filed 2026-07-14 |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 10-Q · filed 2026-02-11 | $0.00 derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 3 quarters · filed 2026-07-14 | $2.00K derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 | $0.00 derived: sum of 2 quarters · filed 2026-07-14 | $2.00K derived: sum of 3 quarters · filed 2026-07-14 | $3.00K derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $2.00K derived: sum of 2 quarters · filed 2026-07-14 | $3.00K derived: sum of 3 quarters · filed 2026-07-14 | $5.00K 10-K · filed 2026-07-14 |
| 2024-12-31 | $2.00K 10-Q · filed 2026-02-11 | $3.00K derived: sum of 2 quarters · filed 2026-02-11 | $5.00K 10-Q · filed 2026-02-11 | |
| 2024-09-30 | $1.00K 10-Q · filed 2025-11-06 | $3.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $2.00K 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $0.00 10-Q · filed 2025-02-19 | $0.00 derived: sum of 2 quarters · filed 2025-02-19 | $0.00 10-Q · filed 2025-02-19 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-05 | |||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $0.00 derived: sum of 2 quarters · filed 2021-06-15 | $0.00 derived: sum of 3 quarters · filed 2021-06-15 | $0.00 10-K · filed 2021-06-15 |
| 2020-12-31 | $0.00 10-Q · filed 2021-02-08 | $0.00 derived: sum of 2 quarters · filed 2021-02-08 | $0.00 10-Q · filed 2021-02-08 | $0.00 derived: sum of 4 quarters · filed 2021-06-15 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 3 quarters · filed 2021-06-15 | $13.00K derived: sum of 4 quarters · filed 2021-06-15 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 2 quarters · filed 2021-06-15 | $13.00K derived: sum of 3 quarters · filed 2021-06-15 | $277.00K derived: sum of 4 quarters · filed 2021-06-15 |
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $13.00K derived: sum of 2 quarters · filed 2021-06-15 | $277.00K derived: sum of 3 quarters · filed 2021-06-15 | $328.00K 10-K · filed 2021-06-15 |
| 2019-12-31 | $13.00K 10-Q · filed 2021-02-08 | $277.00K derived: sum of 2 quarters · filed 2021-02-08 | $328.00K 10-Q · filed 2021-02-08 | $429.00K derived: sum of 4 quarters · filed 2021-02-08 |
| 2019-09-30 | $264.00K 10-Q · filed 2020-11-05 | $315.00K 10-Q · filed 2020-11-05 | $416.00K derived: sum of 3 quarters · filed 2020-11-05 | $552.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $51.00K 10-Q · filed 2020-08-10 | $152.00K derived: sum of 2 quarters · filed 2020-08-10 | $288.00K derived: sum of 3 quarters · filed 2020-08-10 | $413.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | $237.00K derived: sum of 2 quarters · filed 2020-05-28 | $362.00K derived: sum of 3 quarters · filed 2020-05-28 | $482.00K 10-K · filed 2020-05-28 |
| 2018-12-31 | $136.00K 10-Q · filed 2020-02-10 | $261.00K derived: sum of 2 quarters · filed 2020-02-10 | $381.00K 10-Q · filed 2020-02-10 | $664.00K derived: sum of 4 quarters · filed 2020-02-10 |
| 2018-09-30 | $125.00K 10-Q · filed 2019-11-07 | $245.00K 10-Q · filed 2019-11-07 | $528.00K derived: sum of 3 quarters · filed 2019-11-07 | $720.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $120.00K 10-Q · filed 2019-08-08 | $403.00K derived: sum of 2 quarters · filed 2019-08-08 | $595.00K derived: sum of 3 quarters · filed 2019-08-08 | $849.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03 | $475.00K derived: sum of 2 quarters · filed 2019-06-03 | $729.00K derived: sum of 3 quarters · filed 2019-06-03 | $1.03M 10-K · filed 2019-06-03 |
| 2017-12-31 | $192.00K 10-Q · filed 2019-02-07 | $446.00K derived: sum of 2 quarters · filed 2019-02-07 | $747.00K 10-Q · filed 2019-02-07 | |
| 2017-09-30 | $254.00K 10-Q · filed 2018-11-08 | $555.00K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $301.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |